Current Events

This six-day course is taught by five Virginia Tech professors and is designed for all education levels. Students can expect to learn about polymer synthesis, molecular weight determination, characterization of rheological and viscoelastic behavior; gain a better understanding of polymer structure and morphology, and mechanical testing; study elastomers, plastics, and fibers; learn from practical examples from fields of adhesion and composites; and understand the measurement of properties of polymers, which are then discussed as functions of chemical composition, molecular weight, topology, morphology, etc.

Cells are potential solutions! Cambridge Healthtech Institute's Third Annual CELLutions SUMMIT is uniquely designed to explore the evolving field of next-generation cells, engineered 3D cellular models, and therapeutic cellular-in-human use. Scientific technological progress brings fundamental understanding and provides the foundation for more rapid advances toward the clinic. Targeted Topics: • Cell Sources • 3D Cellular Models • Cell Therapies • Five @ Five www.CELLutionsSUMMIT.com

This course is designed for beginners and intermediate-level practitioners who want practical laboratory experience in gas chromatography .The lectures, supplemented by problem sets, slides, and video presentations, provide the fundamentals needed to understand the technique and instrumentation involved in this powerful analytical tool. At the end of the class, you will have mastered the fundamentals of GC, participated in five hands on laboratory sessions, performed reference and literature searches and learned specialized techniques based on your specific interests.

• Novel Vaccines: Bridging Research, Development & Production • Advances in Cancer Vaccines • Clinical Risk Management & Safety for Vaccines www.TargetedImvacS.com

The 236th ACS National Meeting & Exposition will take place August 17-21, 2008 in Philadelphia, Pennsylvania. Events will be held at the Pennsylvania Convention Center and hotels around the city. The technical program will feature original programming hosted by 31 technical divisions, one secretariat, three committees, and the ACS president and will include thematic programming around "Chemistry for Health: Catalyzing Translational Research."

At this year ’s Systems Integration in Biodefense meeting, we will hear from industry leaders about their strategy for meeting the needs of the community and bridging the technology gaps that still exist. New assays will be introduced that are highly multiplexed, integrated and field deployable. Technology developments in sample prep, signal transduction and amplification will be showcased, and specific examples of creating an integrated system will be presented. Dual-use application is an essential feature for products to have utility in biodefense and clinical settings. A discussion on getting products to market and facing commercialization, collaboration, and business challenges will be addressed. The meeting will be followed by the 2nd Annual Enabling Point-of-Care Diagnostics to elucidate the transition from biodefense to a clinical setting, and the tactical issues of implementation. www.healthtech.com

The POC diagnostics industry is rapidly expanding, and promises to answer the need for more integrated and immediate clinical results. Technologies are being developed that will integrate with the health information infrastructure to allow fast, accurate and easy-to-use assays. These can be used in global health and crisis response environments, as well as in clinical settings. Applications in stroke, respiratory disease, cardiac treatment will be featured that will take into consideration the unmet clinical need and the technology development that is unique to each application. The need for generating reliable data and reducing costs will be weighed against other requirements. www.healthtech.com

Advances in molecular diagnostics has enabled the detection of early stage tumors that will lead to greater success rates with intervention and treatment. Tests are being commercialized that employ a variety of approaches utilizing gene expression, serum biomarkers, and circulating tumors cells to capture information early for non-invasive screening of selected populations. Technologies to resolve and isolate the earliest stages of disease can be used in some cases in combination with imaging techniques to differentiate between benign vs. malignant tumors. The potential for these assays to greatly improve patient survival and care is historic and opportune and will further allow the tracking of disease progression. www.healthtech.com

This course is designed for beginners and intermediate-level users in HPLC who want practical laboratory experience. The lectures, supplemented by problems sets, slides, and video presentations, provide the fundamentals needed to understand the techniques and instrumentation involved in this powerful analytical tool. Key topics include: basic instrumentation for HPLC; detectors, including UV/VIS, photo diode array, mass spectrometer, and fluorescence; column selection and optimization, qualitative and quantitative analysis; and troubleshooting HPLC systems.

The conference covers all aspects of physical chemistry.

BioPharm America is where biotech industry partnerships get started. Based on the same winning formula used in EBD Group’s distinguished European partnering conferences BIO-Europe and BIO-Europe Spring®, BioPharm America is expected to become the premier stand-alone bio-pharma partnering event in North America. With a clear focus on generating one-to-one meetings for attendees, BioPharm America offers an unrivalled opportunity for participants across the entire biotech value-chain to identify and enter into strategic relationships.

Conference chairs Zheng Yang of Bristol-Myers Squibb and Ellen Q. Wang of Pfizer will present the 3rd annual ACS ProSpectives conference on pharmacokinetics (PK) and pharmacodynamics (PD). This conference is specifically designed for medicinal chemists and team leaders directly involved in the discovery and early development of new drugs who want to learn more about PK-PD and applying it to drug design.

Conference chairs Zheng Yang of Bristol-Myers Squibb and Ellen Q. Wang of Pfizer will present the 3rd annual ACS ProSpectives conference on pharmacokinetics (PK) and pharmacodynamics (PD). This conference is specifically designed for medicinal chemists and team leaders directly involved in the discovery and early development of new drugs who want to learn more about PK-PD and applying it to drug design. The 2-day conference will move from the basic concepts and principles of PK-PD to the application of these concepts to drug discovery programs from various therapeutic areas, including,  Neuroscience  Oncology  Immunology  Metabolic diseases Each session will be highlighted with a case study from the medicinal chemistry perspective that demonstrates the value of understanding PK-PD relationships in the design of better drug molecules.

BioPharm America is where biotech industry partnerships get started. Based on the same winning formula used in EBD Group’s distinguished European partnering conferences BIO-Europe and BIO-Europe Spring®, BioPharm America is expected to become the premier stand-alone bio-pharma partnering event in North America. With a clear focus on generating one-to-one meetings for attendees, BioPharm America offers an unrivalled opportunity for participants across the entire biotech value-chain to identify and enter into strategic relationships.

This conference & exhibition is a major international forum for the discussion of technical aspects of scale-up at the chemistry/chemical engineering interface in the pharmaceutical, fine chemical and allied fields. Topics include: the scale-up of batch and semi-batch processes, continuous processing and reaction engineering, microreactor technology, safety and thermochemistry, scale-up of potentially hazardous chemistry, green chemistry, quality assurance and regulatory concerns, solid form control (crystallisation & polymorphism), separation and purification techniques, and new technologies and equipment for large scale manufacture.

Optimizing Cell Culture Development will include talks from industry experts that address critical issues in an atmosphere that encourages sharing, learning, and networking. The agenda will again feature small-group breakout discussions that will provide the opportunity to discuss important topics with your peers in a fun and collegial setting. In addition, case studies will be presented that shed light on improving yield while maintaining product quality within the regulatory framework. www.healthtech.com

Sought by most international pharmaceutical and biotechnology companies, China has become a partner of choice for international biopharmaceutical companies. In order to minimize unnecessary expenses, time and risk involved in R&D, companies have found an effective solution and worthy partner in this low-cost region populated by a highly-skilled drug discovery and development talent pool. In addition, due to its growing western-educated middle class, China presents valuable commercial opportunities for pharmaceutical and biotechnology companies. www.healthtech.com

The Baculovirus Technology meeting will bring together experts who are achieving breakthroughs and clinical success. Innovative approaches to tackling the problems of increasing protein expression levels and humanizing the N-glycosylation pathway will be addressed, along with case studies from industry leaders. www.healthtech.com